Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares Nuvalent Inc NUVL Q1 2026 Earnings Slightly Wider Loss No Revenue Yet as PreClinical Pipeline Progresses IRWD Q1 2026 Earnings Slight EPS Miss Offset by Investor Optimism ATAT Q1 2026 Earnings Strong EPS Beat Drives Stock Higher FIGS Q1 2026 Earnings Strong EPS Surprise Highlights Margin Improvement Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips